Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥4,552 | CN¥6,395 | CN¥8,767 | CN¥11,219 |
| - Cash | CN¥918 | CN¥1,025 | CN¥859 | CN¥981 |
| + Debt | CN¥414 | CN¥444 | CN¥651 | CN¥653 |
| Enterprise Value | CN¥4,048 | CN¥5,815 | CN¥8,559 | CN¥10,890 |
| Revenue | CN¥3,373 | CN¥3,538 | CN¥3,506 | CN¥3,138 |
| % Growth | -4.7% | 0.9% | 11.7% | – |
| Gross Profit | CN¥1,354 | CN¥1,465 | CN¥1,620 | CN¥1,651 |
| % Margin | 40.1% | 41.4% | 46.2% | 52.6% |
| EBITDA | CN¥606 | CN¥564 | CN¥629 | CN¥448 |
| % Margin | 18% | 15.9% | 17.9% | 14.3% |
| Net Income | CN¥197 | CN¥175 | CN¥273 | CN¥108 |
| % Margin | 5.8% | 4.9% | 7.8% | 3.4% |
| EPS Diluted | 0.52 | 0.46 | 0.71 | 0.28 |
| % Growth | 13% | -35.2% | 153.6% | – |
| Operating Cash Flow | CN¥297 | CN¥664 | CN¥256 | CN¥437 |
| Capital Expenditures | -CN¥143 | -CN¥343 | -CN¥374 | -CN¥376 |
| Free Cash Flow | CN¥154 | CN¥321 | -CN¥118 | CN¥61 |